Enlivex Therapeutics Stock Price - ENLV

9.32
-0.0791 (-0.84%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Enlivex Therapeutics Ltd ENLV NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.4392 4.9% 9.3991 9.058 9.44 9.19 8.9599 19:00:05
Bid Price Ask Price Spread Spread % News
5.90 17.10 11.20 65.5% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
60 9,604 $ 9.30 $ 89,278 17,131 1.23 - 44.90
Last Trade Time Type Quantity Stock Price Currency
16:00:00 16 $ 9.32 USD

Enlivex Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 97.13M 10.33M $ -4.24M -6.78 - 10.33M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Enlivex Therapeutics News

Date Time Source News Article
2/20/202008:38GlobeNewswire Inc.Data On Enlivex’s Allocetra-OTS Immunotherapy for Peritoneal..
2/14/202006:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
1/31/202016:32Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private..
1/23/202016:32Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private..
11/20/201916:47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/20/201916:14GlobeNewswire Inc.Enlivex Therapeutics Ltd. Announces Proposed Offering of..
11/18/201908:30GlobeNewswire Inc.Enlivex Therapeutics Completes Recruitment In Phase Ib Trial..

Latest ENLV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENLV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.209.508.1618.9310,8881.2014.62%
1 Month9.709.706.888.1410,297-0.3009-3.1%
3 Months8.6110.616.888.7913,4210.78919.16%
6 Months27.5044.906.2510.8243,261-18.10-65.82%
1 Year1.5744.901.2310.9732,5797.83498.67%
3 Years5.8544.900.77383.3282,7833.5560.67%
5 Years33.5544.900.77384.9057,505-24.15-71.98%

Enlivex Therapeutics Description

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Your Recent History
NASDAQ
ENLV
Enlivex Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200223 23:31:40